Dc. Gore et G. Sutherland, Gut gavage with antiendotoxin antibodies reduces the liberation of tumor necrosis factor-alpha after hemorrhage/resuscitation, CRIT CARE M, 28(7), 2000, pp. 2425-2428
Objective: To evaluate the effect of gut gavage both alone and with enteral
administration of monoclonal antibodies to endotoxin on the liberation of
tumor necrosis factor (TNF)-alpha and subsequent hemodynamics after hemorrh
age/resuscitation.
Design: Dose response intervention, sham-controlled animal study.
Setting: Research laboratory at a university medical center.
Animals: Instrumented rats (250-325 g body weight) underwent standardized h
emorrhage/resuscitation.
Interventions: Animal groups received 4 hrs before hemorrhage/resuscitation
: gastric gavage with Colyte alone (group 1), combined with E-5 antiendotox
in at either 0.2 mg/100 g (group 2) or 2 mg/100 II body weight (group 3), o
r sham controls (group 4). There were six animals studied in each of the fo
ur groups.
Measurements and Main Results:For animals receiving gut gavage and high-dos
e E-5 antiendotoxin, plasma concentrations of TNF-alpha (pg/mL) at 120 m in
s after hemorrhage/resuscitation were significantly lower compared with sha
m controls (16 +/- 4 group 3; 65 +/- 36 group 4; mean +/- SD, p < .05). At
300 mine, this same treatment group had a significantly higher mean blood p
ressure (mm Hg) (110 +/- 6 group 3; 86 +/- 7 group 4: p < .05). Also at 300
mins after hemorrhage/resuscitation, plasma lactate concentrations (mmol/L
) were significantly lower for all gut gavage treatment groups compared wit
h sham control animals (1.9 +/- 0.2 group 1; 2.0 +/- 0.2 group 2; 1.8 +/- 0
.2 group 3; 4.8 +/- 2.8 group 4, p < .05).
Conclusions: Prior treatment with gut gavage and enterally administered ant
iendotoxin antibodies reduces TNF-alpha liberation after hemorrhage/resusci
tation and confers a subsequent improvement in hemodynamics and decreased p
lasma lactate concentrations. Such therapy may be efficacious in patients u
ndergoing elective procedures where major hemorrhage is likely or in severe
ly injured patients with continued or recurrent hemorrhage.